Skip to content
My WebMD Sign In, Sign Up

Hepatitis Health Center

Font Size

Hepatitis C: Less Treatment OK for Some

Study Shows Successful Outcomes for Patients Who Quit Drug Therapy Early

Customizing HCV Treatment

Both studies suggest that customizing treatment length based on early therapeutic responses could improve patient cure rates.

University of North Carolina hepatitis C expert Michael W. Fried, MD, agrees, but he adds that more research is needed to better understand how to best tailor treatments based on patient responses.

He points out that response rates were slightly better among early responders treated for the recommended times in both studies.

Fried is a professor of medicine and director of hepatology at the University of North Carolina at Chapel Hill.

"Response rates were similar, but they were not identical," he says. "There was still about a 10% drop in sustained responses among patients treated for shorter periods."

Fried says the findings may have the biggest implications for patients who respond to treatment but have trouble staying on it.

"People who are not tolerating treatment well or who may be anxious to stop may be able to stop early without too much risk," he says.

1|2

Today on WebMD

Hepatitus C virus
Slideshow
young couple
Article
 
Hepatitis Basics
Article
Hepatitis Prevent 10
Article
 
Hepatitis C Treatment
Article
Syringes and graph illustration
Tool
 
liver illustration
Quiz
passport, pills and vaccine
Slideshow
 
Scientist looking in microscope
Slideshow
Fatty Liver Disease
Article
 
Digestive Diseases Liver Transplantation
Article
Picture Of The Liver
Image Collection
 

WebMD Special Sections